Gemcitabine/Nab-Paclitaxel With HIGRT in Resectable Pancreatic Cancer
Clinical trial NCT02318095 · COMPLETED
Trial details
- NCT number
- NCT02318095
- Sponsor
- Duke University
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-17
- Primary completion
- 2018-11-07
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.